Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

The National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science, and/or spectroscopic technologies into methods or tools that address contemporary problems in understanding the fundamental biology, potential risk of development, diagnosis, treatment, and/or disease status for cancer or other diseases. The grant aims to support Academic-Industrial Partnerships (AIP) to translate and validate in vivo imaging systems. Key aspects of the job include: * Translating scientific discoveries and engineering developments into methods or tools for cancer or other diseases * Validating in vivo imaging systems * Addressing contemporary problems in understanding the fundamental biology, potential risk of development, diagnosis, treatment, and/or disease status for cancer or other diseases * Supporting Academic-Industrial Partnerships (AIP)